Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Microneedle array Japanese encephalitis vaccine dose-response trial in healthy adults
jRCTs011190004Completed
- Sponsor
- Fujifilm
- Start
- Jul 2019
- Modality
- Live Attenuated Vaccines → Live Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Trial of Japanese encephalitis vaccine in Japanese encephalitis (JE) (3 arms), sponsored by Fujifilm. Primary endpoint: Neutralizing antibody titer at 6 weeks. Started Jul 2019; status: completed.
02
Drugs
Japanese encephalitis vaccine
03
Conditions
Japanese encephalitis (JE)
Beyond the preview
Go deeper on jRCTs011190004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs011190004.